CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.18B, above the global median of $1.15B
- FinancialsAltman Z-Score 4.9: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.47%Below 5Y avg (4.27%)
Annual Rate
CNY 0.20Paid annual
Payout Ratio
0.0%Sustainable
Payback Period
65.2 yr
Last Ex-Dividend
Jul 17, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
7.95BCNY1.18B · vs all stocks (USD)
Revenue (TTM)
2.50BCNY371.06M · vs all stocks (USD)
Profit Margin
-8.19%Beta
0.2600xvs all stocks
52-Week Change
-16.18%vs all stocks
Market Capitalization
7.95BCNY1.18B · vs all stocks (USD)
Enterprise Value
5.36BCNY796.43M · vs all stocks (USD)
Forward P/E
5.62xPrice to Sales (TTM)
3.11xPrice to Book (MRQ)
1.97xEnterprise to Revenue
2.15xEnterprise to EBITDA
-131.04xGross Margin
56.34%Profit Margin
-8.19%Operating Margin
18.68%Return on Assets (TTM)
-2.29%Return on Equity (TTM)
-5.49%Revenue (TTM)
2.50BCNY371.06M · vs all stocks (USD)
Revenue per Share (TTM)
4.25CNYUpdated Aug 20, 2026Quarterly Revenue Growth
27.20%Gross Profit (TTM)
1.07BCNY159.56M · vs all stocks (USD)
EBITDA (TTM)
-40.92MCNY-6.08M · vs all stocks (USD)
Net Income (TTM)
-204.65MCNY-30.40M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
93.10%Operating Cash Flow (TTM)
551.36MCNY81.89M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
552.70MCNY82.09M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.2000CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
1.47%vs all stocks
5-Year Average Dividend Yield
4.27%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
152.37MCNYFY2025 · Dec 31, 2025Revenue
2.32BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.43BCNYFY2025 · Dec 31, 2025Gross Profit
884.35MCNYFY2025 · Dec 31, 2025Operating Income
-212.03MCNY-31.49M · vs all stocks (USD)
Pre-tax Income
-271.15MCNYFY2025 · Dec 31, 2025Income Tax Expense
25.92MCNYFY2025 · Dec 31, 2025Net Income
-297.07MCNYFY2025 · Dec 31, 2025EBIT
-267.46MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-20.11MCNYFY2025 · Dec 31, 2025Research & Development
111.11MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
581.28MCNYFY2025 · Dec 31, 2025Other Operating Expenses
43.71MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
8.46MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
3.69MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.4400CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.4400CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
585.97MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
585.97MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-297.07MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
39.25MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
334.33MCNYFY2025 · Dec 31, 2025Free Cash Flow
238.75MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
849.92MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-297.07MCNYFY2025 · Dec 31, 2025Other Non-cash Items
8.44MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
421.49MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
201.48MCNYFY2025 · Dec 31, 2025Capital Expenditures
-95.58MCNYFY2025 · Dec 31, 2025Purchase of Investments
-9.81BCNYFY2025 · Dec 31, 2025Sale of Investments
9.35BCNYFY2025 · Dec 31, 2025Other Investing Activity
-62.94KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-552.62MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
118.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-13.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-292.12MCNYFY2025 · Dec 31, 2025Other Financing Charges
-4.12MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-191.25MCNYFY2025 · Dec 31, 2025Shares Outstanding
584.00MSharesUpdated Aug 20, 2026Float Shares
250.93MSharesUpdated Aug 20, 2026% Held by Insiders
57.36%vs all stocks
% Held by Institutions
4.28%vs all stocks
Total Cash (MRQ)
2.67BCNY397.09M · vs all stocks (USD)
Total Cash per Share (MRQ)
4.58CNYUpdated Aug 20, 2026Total Debt (MRQ)
111.00MCNY16.49M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0270xCurrent Ratio (MRQ)
3.33xBook Value per Share (MRQ)
6.76CNYUpdated Aug 20, 2026Total Assets
5.33BCNY791.36M · vs all stocks (USD)
Total Current Assets
3.50BCNYFY2025 · Dec 31, 2025Total Liabilities
1.34BCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.83BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
186.14MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.15BCNYFY2025 · Dec 31, 2025Cash
848.18MCNYFY2025 · Dec 31, 2025Cash Equivalents
4.64MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
852.82MCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.76BCNYFY2025 · Dec 31, 2025Accounts Receivable
62.15MCNYFY2025 · Dec 31, 2025Inventory
617.43MCNYFY2025 · Dec 31, 2025Accounts Payable
421.62MCNYFY2025 · Dec 31, 2025Short-term Debt
112.93MCNYFY2025 · Dec 31, 2025Other Current Liabilities
9.80MCNYFY2025 · Dec 31, 2025Long-term Debt
3.00MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
1.30MCNYFY2025 · Dec 31, 2025Common Stock (Book)
584.00MCNYFY2025 · Dec 31, 2025Retained Earnings
2.02BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.99BCNY592.69M · vs all stocks (USD)
52-Week Low
11.04CNYUpdated Aug 20, 202652-Week High
16.42CNYUpdated Aug 20, 202652-Week Change
-16.18%vs all stocks
Beta
0.2600xvs all stocks
50-Day MA
12.86CNYUpdated Aug 20, 2026200-Day MA
13.59CNYUpdated Aug 20, 2026Avg 10-Day Volume
5.79MSharesUpdated Aug 20, 2026Avg 30-Day Volume
7.65MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
-0.3500CNYUpdated Aug 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.56Profit Margin: -0.08
Financial Health
Altman Z-Score 4.9: safe zoneNotable
Altman Z-Score: 4.90
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.18B, above the global median of $1.15BNotable
Market cap (USD): 1,181,339,961.6Global Median: 1,146,734,693.424
Levered free cash flow is $82.09M, above the global median of $16.24MNotable
Levered free cash flow (USD): 82,086,771.121Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Guangzhou Wondfo Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
QuidelOrtho Corporation
Tier 1ProductionApproval-Gated PipelineRule
0009K0
Tier 1ProductionApproval-Gated PipelineRuleRisk
Zhejiang Garden Bio-chemical High-tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tandem Diabetes Care Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Collegium Pharmaceutical Inc.
Tier 1ProductionApproval-Gated PipelineRule
Avanos Medical Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Jiuzhitang Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Glass House Brands Inc.
Tier 1ProductionApproval-Gated PipelineFlowRule
Guilin Sanjin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule